← FDA DRUG APPROVALS

FDA ANDA · ANDA086454

AMITID

Sponsor: BRISTOL MYERS SQUIBB

APPLICATION
ANDA086454
TYPE
ANDA
ORIGINAL APPROVAL
1978-10-19
LATEST ACTION
1978-10-19
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

AMITIDDiscontinued
AMITRIPTYLINE HYDROCHLORIDE 75MG · TABLET · ORAL
AMITIDDiscontinued
AMITRIPTYLINE HYDROCHLORIDE 25MG · TABLET · ORAL
AMITIDDiscontinued
AMITRIPTYLINE HYDROCHLORIDE 100MG · TABLET · ORAL
AMITIDDiscontinued
AMITRIPTYLINE HYDROCHLORIDE 50MG · TABLET · ORAL
AMITIDDiscontinued
AMITRIPTYLINE HYDROCHLORIDE 10MG · TABLET · ORAL

Approval history

1978-10-19OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →